LASIK induces visual improvements faster than LASEK

Article

Visual improvements for low myopia is significantly slower after LASEK than after LASIK, according to a study published in the February issue of the Journal of Refractive Surgery.

Visual improvements for low myopia is significantly slower after LASEK than after LASIK, according to a study published in the February issue of the Journal of Refractive Surgery.

Laura de Benito-Llopis and colleagues from the Vissum Corporación, Universidad de Alcalá and the Universidad Complutense, Madrid, Spain enrolled 79 eyes to the LASEK group and 79 eyes to the LASIK group in a prospective, interventional, non-randomized, observer-masked study. Each subject had myopia of < -2.50 D. Refractive analysis was performed preoperatively and one day, one week and one and three months postoperatively.

Postoperative uncorrected visual acuity (UCVA) was significantly lower in LASEK eyes at one and seven days postoperatively (p=0.0001). At one and three months, no significant differences were noted between the groups in UCVA, however, best spectacle corrected visual acuity (BSCVA) at three months was significantly better in LASEK eyes (p=0.01). The refractive error was similar in both groups (p=0.3).

The researchers found that, although postoperative UCVA was similar in both groups at three months, the LASEK subjects were slower in reaching this level.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.